Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
NCT02760498
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
432
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cutaneous Squamous Cell Carcinoma
Interventions
DRUG:
cemiplimab
Sponsor
Regeneron Pharmaceuticals